Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Clinical trial NCT02314676 · UNKNOWN
Trial details
- NCT number
- NCT02314676
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-07-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.